Page 2 - Johnf Thero News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Danaher, Novocure rise; Amarin, American Airlines fall by The Associated Press Last Updated Apr 13, 2021 at 4:44 pm EDT Stocks that traded heavily or had substantial price changes Tuesday: TransDigm Group Inc., down $5.31 to $618.33. The aircraft parts maker is selling its Technical Airborne Components business to Searchlight Capital Partners. Fastenal Co., down 73 cents to $49.98. The distributor of nuts, bolts and screws told investors that it is seeing rising pressure on costs. Danaher Corp., up $8 to $242.84. The industrial and medical device maker gave investors an encouraging first-quar...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Amarin Corporation plcFebruary 25, 2021 GMT Record Revenue of $614.1 Million and $167.3 Million for Full Year and Fourth Quarter 2020 Despite COVID-19 Impact Received Positive CHMP Opinion for VAZKEPA ® in Europe and Continue to Advance Commercial Launch Plans for Europe Management to Host Conference Call Today at 7:30 a.m. ET DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Amar...

(MENAFN - GlobeNewsWire - Nasdaq) DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN ) today announced that John F. Thero, Amarin's president and chief executive officer, is scheduled to present general company updates at the following investor conferences scheduled in February and March: 10th Annual SVB Leerink Global Healthcare conference on Friday, February 26, 2021 at 9:20 a.m. Eastern Time (ET) Cowen 41st Annual Health Care conference on Monday, March 1, 2021 at 10:20 a.m. Eastern Time (ET) Live audio webcasts of the presenta...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amarin Provides Preliminary 2020 Results and 2021 Outlook Amarin Corporation plcJanuary 7, 2021 GMT Unaudited 2020 Total Net Revenue Estimated to Be Approximately $610 Million, an Increase of Approximately 42% Compared with 2019 Completion of European Regulatory Review and Submission of China Regulatory Application for VASCEPA® (icosapent ethyl) Expected in Late January or February 2021 DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) tod...